FKK-10238-71054
3 vaccinations
3 coded responses
35 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 644 / MO
- Registered
- 2021-07-20
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-07-20
Registered in v-safe
-
2021-07-20
Dose 1 — Pfizer-BioNTech
- 2021-07-20
- 2021-07-21
- 2021-07-22
- 2021-07-23
- 2021-07-24
- 2021-07-25
- 2021-07-26
- 2021-07-27
- 2021-08-03
-
2021-08-10
Dose 2 — Pfizer-BioNTech
- 2021-08-10
-
2021-08-11
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-08-12
- 2021-08-13
- 2021-08-14
- 2021-08-15
- 2021-08-16
- 2021-08-17
- 2021-08-24
- 2021-08-31
- 2021-09-07
- 2021-09-14
- 2021-09-21
-
2021-11-09
Survey response — 3 months, dose 2MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend schoolFree text: COVID-19MedDRA releases: 2024-11 · check-in free text available
- 2022-02-08
-
2022-05-19
Dose 3 — Pfizer-BioNTech
-
2022-05-20
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Redness · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2022-05-22
Survey response — days 1–6 daily, dose 3MedDRA: Dizziness — Feeling: Fair · Site: PainFree text: DizzinessMedDRA releases: 2024-11 · check-in free text available
- 2022-05-23
- 2022-05-24
-
2022-05-25
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2022-05-26
- 2022-06-09
- 2022-06-16
- 2022-06-23
- 2022-06-30
-
2022-11-17
Survey response — 6 months, dose 3MedDRA: Abortion spontaneous — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: MiscarriagesMedDRA releases: 2024-11 · check-in free text available
-
2022-11-17
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-11-18
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-07-20 | Pfizer-BioNTech | No |
| 2 | 2021-08-10 | Pfizer-BioNTech | No |
| 3 | 2022-05-19 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-11-17 | Successful 2022-11-18 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 10 — 3 months, dose 2
Symptoms: COVID-19
Release 11 — days 1–6 daily, dose 3
Systemic reaction (other): Dizziness
Release 12 — 6 months, dose 3
Symptoms: Miscarriages
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abortion spontaneous | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SRO | Dizziness | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release